FGR-FUSIONEN

Patent europeic · EP3169804 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3169804
Numer da la dumonda
EP15745320
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Limità
Annunzià
15-07-2015
Publitgà
24-05-2017
Concedì
30-01-2019
Stritgà
31-07-2019
Motiv
Taxa annuala betg pajada
Classas IPC
C12Q 1/68 (2018.01)
Prioritad
US 201462025854 P 17.07.2014
Dumonda PCT
PCT/US2015/040553 15.07.2015
Publicaziun PCT
WO2016/011141 21.01.2016
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 19-02-2020

    Stritgà, taxa betg pajada

    Published in Swissreg on 19.02.2020

  2. 21-08-2019

    Midada

    Published in Swissreg on 21.08.2019

  3. 30-01-2019

    Concedì

    Published in Swissreg on 30.01.2019

Partidas

Possessur

Blueprint Medicines Corporation

38 Sidney Street, suite 200, Cambridge, MA 02139, US

Inventur

STRANSKY, Nicolas

Charlestown, MA 02129, US

CERAMI, Ethan G.

Winchester, MA 01890, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.